ABSORPTION AND EXCRETION OF PENTAZOCINE AFTER ADMINISTRATION BY DIFFERENT ROUTES

[11] INFLUENCE OF ROUTE OF ADMINISTRATION ON AREA UNDER PLASMA CONCENTRATION-TIME CURVE [J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 1969, 58 (01) : 71 - &

[12] HOLLISTER LE, 1963, CLIN PHARMACOL THER, V4, P612

[13] JAFFE JH, 1970, PHARMACOLOGICAL BASI, P259

[14] KEERISZANTO M, 1970, JAMA-J AM MED ASSOC, V213, P384

[15] PHARMACEUTICAL FORMULATION AND THERAPEUTIC EFFICACY [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1961, 177 (10): : 689 - &

[16] LEVY G, 1967, J MOND PHARM, V3, P237

[17] METABOLISM IN VITRO AND IN VIVO OF PENTAZOCINE [J]. BIOCHEMICAL PHARMACOLOGY, 1969, 18 (07) : 1673 - &

[18] DRUG METABOLISM BY INTESTINAL MICROORGANISMS [J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 1968, 57 (12) : 2021 - &

[19] SEARL RO, 1967, CAN MED ASSOC J, V96, P1513

[20] TANNENBAUM PJ, 1968, CLIN PHARMACOL THER, V9, P598

[11] INFLUENCE OF ROUTE OF ADMINISTRATION ON AREA UNDER PLASMA CONCENTRATION-TIME CURVE [J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 1969, 58 (01) : 71 - &

[12] HOLLISTER LE, 1963, CLIN PHARMACOL THER, V4, P612

[13] JAFFE JH, 1970, PHARMACOLOGICAL BASI, P259

[14] KEERISZANTO M, 1970, JAMA-J AM MED ASSOC, V213, P384

[15] PHARMACEUTICAL FORMULATION AND THERAPEUTIC EFFICACY [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1961, 177 (10): : 689 - &

[16] LEVY G, 1967, J MOND PHARM, V3, P237

[17] METABOLISM IN VITRO AND IN VIVO OF PENTAZOCINE [J]. BIOCHEMICAL PHARMACOLOGY, 1969, 18 (07) : 1673 - &

[18] DRUG METABOLISM BY INTESTINAL MICROORGANISMS [J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 1968, 57 (12) : 2021 - &

[19] SEARL RO, 1967, CAN MED ASSOC J, V96, P1513

[20] TANNENBAUM PJ, 1968, CLIN PHARMACOL THER, V9, P598